Literature DB >> 7042761

Biochemical assessment of histochemical methods for oestrogen receptor localisation.

J C Underwood, E Sher, M Reed, J A Eisman, T J Martin.   

Abstract

The biochemical validity of published labelled-ligand and ligand-antibody methods for the histological localisation of oestrogen receptors (ER) in breast carcinomas was assessed by measuring specific and non-specific binding of 3H-oestradiol to pretreated MCF-7 monolayers; the monolayers had been either frozen and thawed, then air-dried or acetone-fixed, or fixed in formaldehyde to reproduce the conditions in published methods. The results indicate that most of the ER in a frozen section is likely to be lost by diffusion into the supernatant incubation medium. Fixation substantially restricts diffusion but reduces specific oestradiol binding and may increase non-specific binding; acetone fixation is particularly deleterious. Preincubation in oestradiol fails to protect the receptor during fixation. We conclude that the published histochemical methods for ER localisation have doubtful validity and should not yet be used in preference to conventional biochemical assays.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7042761      PMCID: PMC497669          DOI: 10.1136/jcp.35.4.401

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  19 in total

1.  The use of anti-steroid antibodies in the characterization of steroid receptors.

Authors:  E Castaneda; S Liao
Journal:  J Biol Chem       Date:  1975-02-10       Impact factor: 5.157

2.  Measurement of the estradiol receptor in human breast tissue by the immobilized antibody method.

Authors:  J Fishman; J H Fishman; J S Nisselbaum; C Menendez-Botet; M K Schwartz; C Martucci; L Hellman
Journal:  J Clin Endocrinol Metab       Date:  1975-04       Impact factor: 5.958

3.  Oestrogen-responsive human breast cancer in long term tissue culture.

Authors:  M E Lippman; G Bolan
Journal:  Nature       Date:  1975-08-14       Impact factor: 49.962

4.  Detection and dynamic localisation of estradiol-receptor complexes in intact target cells by immunofluorescence technique.

Authors:  I Nenci; M D Beccati; A Piffanelli; G Lanza
Journal:  J Steroid Biochem       Date:  1976 Jun-Jul       Impact factor: 4.292

5.  MCF-7; a human breast cancer cell line with estrogen, androgen, progesterone, and glucocorticoid receptors.

Authors:  K B Horwitz; M E Costlow; W L McGuire
Journal:  Steroids       Date:  1975-12       Impact factor: 2.668

6.  Immunofluorescent detection of estrogen receptors in breast cancer. Comparison with dextran-coated charcoal and sucrose gradient assays.

Authors:  L P Pertschuk; E H Tobin; D J Brigati; D S Kim; N D Bloom; E Gaetjens; P J Berman; A C Carter; G A Degenshein
Journal:  Cancer       Date:  1978-03       Impact factor: 6.860

7.  Detection of estrogen receptor in breast and endometrial carcinoma by the immunoperoxidase technique.

Authors:  C R Taylor; C L Cooper; R J Kurman; U Goebelsmann; F S Markland
Journal:  Cancer       Date:  1981-06-01       Impact factor: 6.860

8.  A fluorescent probe for rapid detection of estrogen receptors.

Authors:  B R Rao; C G Fry; S Hunt; R Kuhnel; W B Dandliker
Journal:  Cancer       Date:  1980-12-15       Impact factor: 6.860

9.  Use of polyestradiol phosphate and anti-17 beta estradiol antibodies for the localization of estrogen receptors in target tissues: a critique.

Authors:  B Morrow; I Leav; R A Delellis; S Raam
Journal:  Cancer       Date:  1980-12-15       Impact factor: 6.860

10.  Detection of estrogen binding in human mammary carcinoma by immunofluorescence: a new technic utilizing the binding hormone in a polymerized state.

Authors:  L P Pertschuk
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1976-08
View more
  8 in total

1.  Steroid Probes Conjugated with Protein-Protected Gold Nanocluster: Specific and Rapid Fluorescence Imaging of Steroid Receptors in Target Cells.

Authors:  Chi-Yan Tsai; Chun-Wei Li; Jie-Ren Li; Bo-Han Jang; Shu-Hui Chen
Journal:  J Fluoresc       Date:  2016-05-10       Impact factor: 2.217

2.  Comparative histological, histochemical, immunohistochemical and biochemical studies on oestrogen receptors, lectin receptors, and Barr bodies in human breast cancer.

Authors:  W Remmele; U Hildebrand; H A Hienz; P J Klein; M Vierbuchen; L J Behnken; B Heicke; E Scheidt
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1986

3.  Histochemical demonstration of endogenous estrogen in breast carcinomas: biochemical and clinical correlation.

Authors:  I Katayama; M Shimizu; M Miura; M Maruyama; M Kobayashi; Y Iino; M Izuo; S Wakatsuki
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1984

4.  Immunocytochemical staining of estrogen receptor in paraffin sections of human breast cancer by use of monoclonal antibody: comparison with that in frozen sections.

Authors:  A Shimada; S Kimura; K Abe; K Nagasaki; I Adachi; K Yamaguchi; M Suzuki; T Nakajima; L S Miller
Journal:  Proc Natl Acad Sci U S A       Date:  1985-07       Impact factor: 11.205

5.  Fluorescent ligands, used in histocytochemistry, do not discriminate between estrogen receptor-positive and receptor-negative human tumor cell lines.

Authors:  E M Berns; E Mulder; F F Rommerts; R A Blankenstein; E de Graaf; H J van der Molen
Journal:  Breast Cancer Res Treat       Date:  1984       Impact factor: 4.872

6.  Oestradiol-BSA conjugates for receptor histochemistry: problems of stability and interactions with cytosol.

Authors:  M Binder
Journal:  Histochem J       Date:  1984-09

7.  Cryostat section assay of oestrogen and progesterone receptors in meningiomas: a clinicopathological study.

Authors:  J W Ironside; R D Battersby; V J Dangerfield; M A Parsons; W R Timperley; J C Underwood
Journal:  J Clin Pathol       Date:  1986-01       Impact factor: 3.411

8.  Oestrogen receptor assay of cryostat sections of human breast carcinomas with simultaneous quantitative histology.

Authors:  J C Underwood; V J Dangerfield; M A Parsons
Journal:  J Clin Pathol       Date:  1983-04       Impact factor: 3.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.